Still, the majority of hereditary cases, particularly those with mutations in BRCA1 and BRCA2 and, interestingly, a fraction of sporadic ovarian cancer cases with a similar phenotype, have been postulated to share “BRCAness” [18,110]. This evidence concerns the gene BRCA2 and ovarian cancer.